IJCOPE Journal

UGC Logo DOI / ISO Logo

International Journal of Creative and Open Research in Engineering and Management

A Peer-Reviewed, Open-Access International Journal Supporting Multidisciplinary Research, Digital Publishing Standards, DOI Registration, and Academic Indexing.
Journal Information
ISSN: 3108-1754 (Online)
Crossref DOI: Available
ISO Certification: 9001:2015
Publication Fee: 599/- INR
Compliance: UGC Journal Norms
License: CC BY 4.0
Peer Review: Double Blind
Volume 02, Issue 05

Published on: May 2026

ANTICANCER PROPERTIES OF THEVETIA

Sristy

Dr . Manesh singh

department of Pharmacology

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Abstract

Thevetia peruviana (syn. Cascabela thevetia), a plant belonging to the Apocynaceae family, has long been recognized for its dual nature as both a potent poison and a source of traditional medicines. In recent years, scientific interest has shifted towards its significant potential in oncology. This review synthesizes the current body of research on the anticancer properties of T. peruviana. The plant is a rich reservoir of bioactive compounds, most notably cardiac glycosides (cardenolides) such as thevetin, peruvoside, and neriifolin, which are concentrated in the seeds and other plant parts. In addition, various extracts contain significant amounts of phenolic compounds, flavonoids, and other secondary metabolites. Numerous in vitro studies have demonstrated that extracts from the fruit, leaves, seeds, and latex of T. peruviana exhibit potent cytotoxic and antiproliferative activity against a wide spectrum of human cancer cell lines, including those of the breast, colon, lung, prostate, and liver. The primary mechanism of action is attributed to the inhibition of the Na+/K+-ATPase pump by cardiac glycosides, which disrupts cellular ion homeostasis and triggers downstream signaling cascades. These events culminate in the induction of apoptosis, characterized by caspase activation and PARP cleavage, as well as cell cycle arrest, typically at the G2/M phase. This review consolidates the phytochemical profile of T. peruviana, details its cytotoxic efficacy with specific IC50 values, and elucidates the molecular mechanisms underlying its anticancer effects, highlighting its promise as a source for the development of novel chemotherapeutic agents.

How to Cite this Paper

Sristy, (2026). Anticancer Properties of Thevetia. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(05). https://doi.org/10.55041/ijcope.v2i5.759

Sristy, . "Anticancer Properties of Thevetia." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 05, 2026, pp. . doi:https://doi.org/10.55041/ijcope.v2i5.759.

Sristy, . "Anticancer Properties of Thevetia." International Journal of Creative and Open Research in Engineering and Management 02, no. 05 (2026). https://doi.org/https://doi.org/10.55041/ijcope.v2i5.759.

Search & Index

References


  1. Al-Rajhi, A. M. H., Yahya, R., Abdelghany, T. M., Fareid, M. A., Mohamed, A. M., Amin, B. H., & Masrahi, A. S. (2022). Anticancer, anticoagulant, antioxidant and antimicrobial activities of Thevetia peruviana latex with molecular docking of antimicrobial and anticancer activities. Molecules, 27(10), 3165. https://doi.org/10.3390/molecules27103165

  2. Cheng, H.-Y., Tian, D.-M., Tang, J.-S., Shen, W.-Z., & Yao, X.-S. (2016). Cardiac glycosides from the seeds of Thevetia peruviana and their pro-apoptotic activity toward cancer cells. Journal of Asian Natural Products Research, 18(9), 837–847. https://doi.org/10.1080/10286020.2016.1170814

  3. El Gizawy, H. A., El Zanaty, S. A., El Ghaly, E. M., & Seif-Eldein, N. A. (2023). Thevetia peruviana leaves, HPLC profile, isolation, and in vitro cytotoxicity. RSC Advances, 13(18), 12072–12079. https://doi.org/10.1039/D3RA00588G

  4. El-Sawi, S. A., Maamoun, A. A., Salama, A. H., & Farghaly, A. A. (2020). Chemical profiling of Thevetia peruviana leaves cytotoxic active extracts enhanced by microemulsion formulation. Bulletin of the National Research Centre, 44(93), 1–12. https://doi.org/10.1186/s42269-020-00339-3

  5. Feng, Q., Leong, W. S., Liu, L., & Chan, W. I. (2016). Peruvoside, a cardiac glycoside, induces primitive myeloid leukemia cell death. Molecules, 21(4), 534. https://doi.org/10.3390/molecules21040534

  6. Haldar, S., Karmakar, I., Chakraborty, M., Ahmad, D., & Haldar, P. K. (2015). Antitumor potential of Thevetia peruviana on Ehrlich’s ascites carcinoma-bearing mice. Journal of Environmental Pathology,

  7. Toxicology and Oncology,34(2), 105–113. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2015012604

  8. Kaushik, V., Azad, N., Yakisich, J. S., & Iyer, A. K. V. (2017). Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers. Cell Death Discovery, 3, 17009. https://doi.org/10.1038/cddiscovery.2017.9

Ethical Compliance & Review Process

  • All submissions are screened under plagiarism detection.
  • Review follows editorial policy.
  • Authors retain copyright.
  • Peer Review Type: Double-Blind Peer Review
  • Published on: May 27 2026
CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License
Scroll to Top